Epigenetic indicators of body mass predict survival outcomes in colorectal cancer patients: patient cohort analysis
Tanwei Yuan, Marko Mandic, Xianzhe Li, Melanie Bewerunge-Hudler, Hermann Brenner, Michael Hoffmeister · 2026
Read Epigenetic indicators of body mass predict survival outcomes in colorectal cancer patients: patient cohort analysis by Tanwei Yuan, Marko Mandic, Xianzhe Li, Melanie Bewerunge-Hudler, Hermann Brenner, Michael Hoffmeister (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13218036.txt.
Description
Tanwei Yuan and co-authors examine, in a 2026 cohort analysis, whether blood-based epigenetic scores of body mass predict survival after colorectal cancer. A single weight measurement at diagnosis can mislead, because the disease itself often causes weight loss before diagnosis. Scores built from DNA methylation patterns may capture long-term body fat exposure more steadily.
The analysis drew on 2,126 newly diagnosed patients in the German DACHS study, comparing five methylation-based body mass scores against self-reported weight history. The scores tracked reported body mass across many years, yet they pointed in the opposite direction for survival: higher methylation scores meant higher mortality risk. The strongest score, built from 135 marker sites, carried the clearest signal, and most links appeared in patients whose blood was drawn before chemotherapy or radiotherapy. The authors suggest such scores could sharpen risk grouping beyond reported weight alone.
Catalog record
| CREATOR | Tanwei Yuan, Marko Mandic, Xianzhe Li, Melanie Bewerunge-Hudler, Hermann Brenner, Michael Hoffmeister |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |